Barişta I - Search Results

1

High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomas.

Güllü I, Yalçin S, Tekuzman G, Barişta I, Alkiş N, Celik I, Zengin N, Güler N, Kars A, Baltali E, et al. Güllü I, et al. Among authors: barista i. Cancer Invest. 1996;14(3):239-42. doi: 10.3109/07357909609012146. Cancer Invest. 1996. PMID: 8630686

2

Non-Hodgkin's lymphomas in Turkey: eighteen years' experience at the Hacettepe University.

Barista I, Tekuzman G, Firat D, Baltali E, Kansu E, Kars A, Ozisik Y, Ruacan S, Uzunalimoğlu B, Karaağaoğlu E. Barista I, et al. Jpn J Cancer Res. 1994 Dec;85(12):1200-7. doi: 10.1111/j.1349-7006.1994.tb02930.x. Jpn J Cancer Res. 1994. PMID: 7531679 Free PMC article.

3

Preoperative localization of parathyroid carcinoma using Tc-99m MIBI.

Kitapçi MT, Tastekin G, Turgut M, Caner B, Kars A, Barista I, Bekdik C. Kitapçi MT, et al. Among authors: barista i. Clin Nucl Med. 1993 Mar;18(3):217-9. doi: 10.1097/00003072-199303000-00007. Clin Nucl Med. 1993. PMID: 8462212

4

Non-Hodgkin's lymphomas of the tonsil: a retrospective analysis of twenty-eight patients with primary tonsillary lymphoma.

Barişta I, Tekuzman G, Güllü I, Baltali E, Kars A, Ozişik Y, Güler N, Celik I, Atahan IL, Firat D. Barişta I, et al. Tumori. 1995 Jul-Aug;81(4):234-7. doi: 10.1177/030089169508100403. Tumori. 1995. PMID: 8540117

5

Dramatic response to ifosfamide, mesna and doxorubicin chemotherapy regimen in an adult with clear cell sarcoma of the kidney.

Yalçin S, Barişta I, Tekuzman G, Güllü I, Firat D. Yalçin S, et al. Among authors: barista i. J Urol. 1996 Jun;155(6):2024. J Urol. 1996. PMID: 8618315 No abstract available.

6

Cancer therapy during Ramadan.

Celik I, Barista I, Firat D. Celik I, et al. Among authors: barista i. J Natl Cancer Inst. 1996 Jun 19;88(12):838. doi: 10.1093/jnci/88.12.838. J Natl Cancer Inst. 1996. PMID: 8637051 No abstract available.

7

Solitary phalanx plasmacytoma relapse with disseminated extramedullary plasmacytomas and myeloma after short duration of remission.

Celik I, Baltali E, Barişta I, Tekuzman G, Kansu E, Atahan L, Güngen Y, Firat D. Celik I, et al. Among authors: barista i. Anticancer Res. 1996 Mar-Apr;16(2):959-62. Anticancer Res. 1996. PMID: 8687159

8

Procarbazine, CCNU, vincristine combination in the treatment of brain tumors.

Güllü IH, Celik I, Tekuzman G, Altunbaş M, Güler N, Barişta I, Alkiş N, Yalçin S, Kars A, Baltali E, Kansu E, Firat D. Güllü IH, et al. Among authors: barista i. Tumori. 1996 May-Jun;82(3):228-31. Tumori. 1996. PMID: 8693599

9

Integrating the time factor into the definition of metastasis of unknown origin.

Barista I, Celik I, Güllü I, Hayran M, Akova M. Barista I, et al. J Natl Cancer Inst. 1996 Jan 3;88(1):51. doi: 10.1093/jnci/88.1.51. J Natl Cancer Inst. 1996. PMID: 8847726 No abstract available.

10

Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancer.

Kiraz S, Baltali E, Güler N, Barista I, Benekli M, Celik I, Güllü IH, Kars A, Tekuzman G, Firat D. Kiraz S, et al. Among authors: barista i. J Chemother. 1996 Aug;8(4):310-4. doi: 10.1179/joc.1996.8.4.310. J Chemother. 1996. PMID: 8873839 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters